Phase II Study of Atezolizumab and Tiragolumab With ctDNA for HPV-positive SCC

NCT06762808 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped 0 participants

Conditions

Squamous Cell Carcinoma

Interventions

DRUG: Atezolizumab
DRUG: Talazoparib

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]
[object Object]